CVE-2026-105706SourceCodester Drug Recommendation System cross-site request forgery
Updated under an hour ago ()
Does this affect you?
It affects SourceCodester Drug Recommendation System. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A weakness has been identified in SourceCodester Drug Recommendation System 1.0. Affected is an unknown function. Executing a manipulation can lead to cross-site request forgery. The attack may be performed from remote. The exploit has been made available to the public and could be used for attacks.
- CVSS
- 4.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:R
- Weakness (CWE)
- CWE-352, CWE-862
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulDB
- NVD analysis
- Deferred
- Record last updated
- Oct 6, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
SourceCodester Drug Recommendation System sourcecodester:drug_recommendation_system | 1.0 | CNA record |
References
- https://vuldb.com/vuln/413699vdb-entry
- https://vuldb.com/vuln/413699/ctisignature, permissions-required
- https://vuldb.com/cve/CVE-2026-105706third-party-advisory
- https://vuldb.com/submit/992055third-party-advisory
- https://github.com/hackliu/Vulnerability-Reports/blob/master/Drug-Recommender-Web-App/VULN-06-CSRF-Missing-Tokens.mdexploit
- https://www.sourcecodester.com/product
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.